← brief for 2026-09-24 · Slowing decline

Multiorgan protective therapy for CKM syndrome: the role of GLP-1-based therapies and SGLT2 inhibitors.

Paper A Peer reviewed Meta-analysis or large trial

Key takeaways

This review looks at two new drug types for diabetes. It found that these drugs protect the heart and kidneys. The review cites large studies that show these benefits. This is a strong summary of the evidence for these drugs.

Who did this work

Mayne KJ · Lee MMY · Sattar N · Herrington WG

Source

Paper · PubMed, the drug frontier · 2026 Sep 24
https://pubmed.ncbi.nlm.nih.gov/42786044/